BRPI0408441A - 2-(butil-1-sulfonilamino)-n-[1(r)-(6-metóxi-piridin-3-il)-p ropil]-benzamida, seu emprego como medicamento, assim como preparados farmacêuticos contendo-os - Google Patents
2-(butil-1-sulfonilamino)-n-[1(r)-(6-metóxi-piridin-3-il)-p ropil]-benzamida, seu emprego como medicamento, assim como preparados farmacêuticos contendo-osInfo
- Publication number
- BRPI0408441A BRPI0408441A BRPI0408441-1A BRPI0408441A BRPI0408441A BR PI0408441 A BRPI0408441 A BR PI0408441A BR PI0408441 A BRPI0408441 A BR PI0408441A BR PI0408441 A BRPI0408441 A BR PI0408441A
- Authority
- BR
- Brazil
- Prior art keywords
- benzamide
- sulfonylamino
- pyridin
- methoxy
- propyl
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- -1 (6-methoxy-pyridin-3-yl) -propyl-benzamide Chemical compound 0.000 abstract 1
- 206010003130 Arrhythmia supraventricular Diseases 0.000 abstract 1
- 206010003658 Atrial Fibrillation Diseases 0.000 abstract 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
- 230000001746 atrial effect Effects 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 239000011737 fluorine Substances 0.000 abstract 1
- 229940126601 medicinal product Drugs 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10312073A DE10312073A1 (de) | 2003-03-18 | 2003-03-18 | 2-(Butyl-1-sulfonylamino)-N-[1(R)-(6-methoxy-pyridin-3yl)-propyl]-benzamid, dessen Verwendung als Medikament sowie dieses enthaltende pharmazeutische Zubereitungen |
| PCT/EP2004/002247 WO2004083157A1 (de) | 2003-03-18 | 2004-03-05 | 2-(butyl-1-sulfonylamino)-n-[1(r)-(6-methoxy-pyridin-3-yl)-propyl]-benzamid, dessen verwendung als medikament sowie dieses enthaltende pharmazeutische zubereitungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0408441A true BRPI0408441A (pt) | 2006-04-04 |
Family
ID=32920928
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0408441-1A BRPI0408441A (pt) | 2003-03-18 | 2004-03-05 | 2-(butil-1-sulfonilamino)-n-[1(r)-(6-metóxi-piridin-3-il)-p ropil]-benzamida, seu emprego como medicamento, assim como preparados farmacêuticos contendo-os |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1606237A1 (https=) |
| JP (1) | JP2006520343A (https=) |
| KR (1) | KR20050110681A (https=) |
| CN (1) | CN100361943C (https=) |
| AR (1) | AR043622A1 (https=) |
| AU (1) | AU2004222137A1 (https=) |
| BR (1) | BRPI0408441A (https=) |
| CA (1) | CA2519022A1 (https=) |
| DE (1) | DE10312073A1 (https=) |
| HR (1) | HRP20050815A2 (https=) |
| MA (1) | MA27749A1 (https=) |
| MX (1) | MXPA05009763A (https=) |
| MY (1) | MY176510A (https=) |
| NO (1) | NO20054472L (https=) |
| NZ (1) | NZ542476A (https=) |
| PE (1) | PE20050307A1 (https=) |
| RS (1) | RS20050690A (https=) |
| RU (1) | RU2333202C2 (https=) |
| TW (1) | TW200500342A (https=) |
| WO (1) | WO2004083157A1 (https=) |
| ZA (1) | ZA200506328B (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102004009931A1 (de) * | 2004-02-26 | 2005-09-15 | Aventis Pharma Deutschland Gmbh | Kv1.5-Blocker zur selektiven Steigerung der Vorhofkontraktilität und Behandlung der Herzinsuffizienz |
| US7569589B2 (en) | 2004-07-29 | 2009-08-04 | Merck & Co., Inc. | Potassium channel inhibitors |
| DE102005028845A1 (de) * | 2005-06-22 | 2006-12-28 | Sanofi-Aventis Deutschland Gmbh | Substituierte Heterocyclen, ihre Verwendung als Medikament sowie enthaltende pharmazeutische Zubereitungen |
| WO2007015775A2 (en) * | 2005-07-22 | 2007-02-08 | Merck & Co., Inc. | Potassium channel inhibitors |
| EP2435407B1 (en) * | 2009-05-29 | 2019-12-25 | RaQualia Pharma Inc. | Aryl substituted carboxamide derivatives as calcium or sodium channel blockers |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0472053B1 (en) * | 1990-08-20 | 1998-06-17 | Eisai Co., Ltd. | Sulfonamide derivatives |
| DE10121003A1 (de) * | 2001-04-28 | 2002-12-19 | Aventis Pharma Gmbh | Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
-
2003
- 2003-03-18 DE DE10312073A patent/DE10312073A1/de not_active Withdrawn
-
2004
- 2004-03-05 NZ NZ542476A patent/NZ542476A/en unknown
- 2004-03-05 BR BRPI0408441-1A patent/BRPI0408441A/pt not_active IP Right Cessation
- 2004-03-05 AU AU2004222137A patent/AU2004222137A1/en not_active Abandoned
- 2004-03-05 MX MXPA05009763A patent/MXPA05009763A/es active IP Right Grant
- 2004-03-05 RU RU2005132163/04A patent/RU2333202C2/ru not_active IP Right Cessation
- 2004-03-05 HR HR20050815A patent/HRP20050815A2/xx not_active Application Discontinuation
- 2004-03-05 PE PE2004000245A patent/PE20050307A1/es not_active Application Discontinuation
- 2004-03-05 CA CA002519022A patent/CA2519022A1/en not_active Abandoned
- 2004-03-05 KR KR1020057017498A patent/KR20050110681A/ko not_active Ceased
- 2004-03-05 JP JP2006504553A patent/JP2006520343A/ja not_active Abandoned
- 2004-03-05 RS YUP-2005/0690A patent/RS20050690A/sr unknown
- 2004-03-05 WO PCT/EP2004/002247 patent/WO2004083157A1/de not_active Ceased
- 2004-03-05 CN CNB2004800060168A patent/CN100361943C/zh not_active Expired - Fee Related
- 2004-03-05 EP EP04717628A patent/EP1606237A1/de not_active Withdrawn
- 2004-03-16 AR ARP040100866A patent/AR043622A1/es unknown
- 2004-03-16 TW TW093106899A patent/TW200500342A/zh unknown
- 2004-03-17 MY MYPI20040938A patent/MY176510A/en unknown
-
2005
- 2005-08-08 ZA ZA200506328A patent/ZA200506328B/en unknown
- 2005-09-19 MA MA28502A patent/MA27749A1/fr unknown
- 2005-09-27 NO NO20054472A patent/NO20054472L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PE20050307A1 (es) | 2005-06-08 |
| DE10312073A1 (de) | 2004-09-30 |
| TW200500342A (en) | 2005-01-01 |
| HK1086819A1 (en) | 2006-09-29 |
| RU2005132163A (ru) | 2006-04-10 |
| RS20050690A (sr) | 2008-04-04 |
| MY176510A (en) | 2020-08-12 |
| WO2004083157A1 (de) | 2004-09-30 |
| RU2333202C2 (ru) | 2008-09-10 |
| ZA200506328B (en) | 2006-04-26 |
| MA27749A1 (fr) | 2006-02-01 |
| MXPA05009763A (es) | 2006-01-27 |
| CN100361943C (zh) | 2008-01-16 |
| JP2006520343A (ja) | 2006-09-07 |
| NZ542476A (en) | 2008-05-30 |
| CN1756728A (zh) | 2006-04-05 |
| AU2004222137A1 (en) | 2004-09-30 |
| KR20050110681A (ko) | 2005-11-23 |
| AR043622A1 (es) | 2005-08-03 |
| NO20054472L (no) | 2005-09-27 |
| CA2519022A1 (en) | 2004-09-30 |
| HRP20050815A2 (en) | 2006-09-30 |
| EP1606237A1 (de) | 2005-12-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0214243A (pt) | Derivado de sulfonamida processo para a preparação de um derivado de sulfonamida e seus sais fisiologicamente aceitáveis, composição farmacêutica e uso de um derivado de sulfonamida | |
| BRPI0409182A (pt) | derivados de oxima e seu uso como agentes farmaceuticamente ativos | |
| BR0010498A (pt) | Composições modernas de medicamentos à base de compostos anticolinergicamente ativos e beta-miméticos | |
| BR0017050A (pt) | Oxazolidinonas suebstituìdas e seu emprego na área da coagulação do sangue | |
| BR0013727A (pt) | Derivados de sulfonilcarboxamida, processo para sua preparação e seu uso como medicamento | |
| BR0108893A (pt) | Composição farmacêutica, composto e processo de preparação de compostos | |
| BR0210711A (pt) | Uso de um composto, composição farmacêutica, composto, e, processo para a preparação de um composto | |
| BR0116084A (pt) | Amidas de ácido furanocarboxìlico e tiofenocarboxìlico ariladas com efeito bloqueador de canal de potássio | |
| BR0213242A (pt) | Composto ou um seu sal ou solvato, composto e seus sais de adição de ácido fisiologicamente aceitáveis, composição farmacêutica, método de tratamento de um ou mais distúrbios, uso de um composto, e, processo de preparação de um composto | |
| AR039978A1 (es) | Tratamiento y prevencion de la osteoporosis | |
| PT1256588E (pt) | Derivados de pirazina originais ou os seus sais, preparacoes farmaceuticas, contendo os derivados ou os seus sais e produtos intermedios para a preparacao de ambos | |
| BRPI0410477A (pt) | composto ou um sal farmaceuticamente aceitável do mesmo, método para a profilaxia ou tratamento de uma condição quiral em um mamìfero, formulação farmacêutica, combinação, uso de um composto, e, processo para preparar um composto | |
| SE9901573D0 (sv) | New compounds | |
| BRPI0413062A (pt) | compostos de sulfonamida, processos de obtenção de seus derivados, seus medicamentos e usos | |
| BRPI0416854A (pt) | suspensões aquosas de ciclesonida para nebulização | |
| EP1663220A4 (en) | PROCESS, SALTS, COMPOSITIONS AND USE | |
| BR9914929A (pt) | Fenil - alquenoil - guanidinas substituìdas de ácido biliar, processos para a sua preparação, sua aplicação como medicamentos ou agentes diagnósticos, assim como medicamento contendo as mesmas | |
| BRPI0408689A (pt) | derivados de benzenosulfonamida, método para preparação e utilização disso para o tratamento da dor | |
| BR0311747A (pt) | Composição farmacêutica, forma de dose simples ou de múltiplas doses da composição, kit, e, método para tratar doença | |
| BRPI0408441A (pt) | 2-(butil-1-sulfonilamino)-n-[1(r)-(6-metóxi-piridin-3-il)-p ropil]-benzamida, seu emprego como medicamento, assim como preparados farmacêuticos contendo-os | |
| BR0116653A (pt) | Medicamento contendo uma poliamina como substância ativa | |
| BR9803367A (pt) | Cromanos substituìdos por sulfonamida, processos para a sua preparação, seu emprego como medicamento e preparados farmacêuticos contendo os mesmos | |
| SE9901572D0 (sv) | New compounds | |
| BRPI0410239A (pt) | composto de 4-(2-furoil)aminopiperidina e medicamento | |
| JP5650642B2 (ja) | メチオニンアナログおよびそれらを使用する方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 7A E 8A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012. |